GLYCOMIMETICS INC Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
ADC Discovery and Option Agreement, dated October 28, 2024, by and among Paragon Therapeutics, Inc., Parascent Holding LLC and Crescent Biopharma, Inc
GLYCOMIMETICS INC
Biotechnology
2025
Offer Letter, dated December 20, 2024, by and between Crescent Biopharma, Inc. and Barbara Bispham
GLYCOMIMETICS INC
Biotechnology
2025
Antibody Discovery and Option Agreement, dated September 19, 2024, by and among Paragon Therapeutics, Inc., Parascent Holding LLC and Crescent Biopharma, Inc
GLYCOMIMETICS INC
Biotechnology
2025
Offer Letter, dated November 15, 2024, by and between Crescent Biopharma, Inc. and Ryan Lynch
GLYCOMIMETICS INC
Biotechnology
2025
Offer Letter, dated November 27, 2024, by and between Crescent Biopharma, Inc. and Christopher Doughty
GLYCOMIMETICS INC
Biotechnology
2025
Description of Certain of Registrant's Securities
GLYCOMIMETICS INC
Biotechnology
2025
Form of Lock-Up Agreement
GLYCOMIMETICS INC
Biotechnology
2024
Form of Crescent Support Agreement
GLYCOMIMETICS INC
Biotechnology
DE
2024
Form of GlycoMimetics Support Agreement
GLYCOMIMETICS INC
Biotechnology
DE
2024
GlycoMimetics, Inc. Amended and Restated Inducement Plan dated as of January 21, 2022
GLYCOMIMETICS INC
Biotechnology
DE
2022
GlycoMimetics, Inc. Inducement Plan
GLYCOMIMETICS INC
Biotechnology
DE
2020
Description of Certain of Registrants Securities
GLYCOMIMETICS INC
Biotechnology
2020